|
NKIRAS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.63980999999813E-05 |
| Normal-vs-Stage3 |
1.9725000000026E-06 |
| Normal-vs-Stage4 |
9.080600E-03 |
| Stage1-vs-Stage2 |
5.003600E-01 |
| Stage1-vs-Stage3 |
4.960000E-01 |
| Stage1-vs-Stage4 |
7.001200E-01 |
| Stage2-vs-Stage3 |
2.672000E-01 |
| Stage2-vs-Stage4 |
5.004800E-01 |
| Stage3-vs-Stage4 |
9.617200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
3.32889271703607E-12 |
| Normal-vs-Asian |
5.422200E-02 |
| Caucasian-vs-AfricanAmerican |
5.174600E-01 |
| Caucasian-vs-Asian |
7.014600E-01 |
| AfricanAmerican-vs-Asian |
8.551800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
2.41784370302867E-12 |
| Male-vs-Female |
7.283000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.60869999998869E-06 |
| Normal-vs-Extreme_Weight |
7.43849426498855E-15 |
| Normal-vs-Obese |
5.05684383256266E-12 |
| Normal-vs-Extreme_Obese |
1.797670E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.401800E-01 |
| Normal_Weight-vs-Obese |
3.424000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.100200E-01 |
| Extreme_Weight-vs-Obese |
8.200200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.820800E-01 |
| Obese-vs-Extreme_Obese |
4.037400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.74780000003783E-06 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
9.99200722162641E-16 |
| Normal-vs-Age(81-100Yrs) |
7.571900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.738800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.219400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.607000E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.156600E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.222600E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.550400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
3.86780000000142E-05 |
| Normal-VS-KIRP CIMP |
7.77780000000838E-05 |
| Normal-VS-Unclassified PRCC |
1.29040000018676E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.5943000031271E-08 |
| Type1 PRCC-VS-KIRP CIMP |
6.298400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.404610E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.723500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.888110E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.310600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.65570004770655E-09 |
| Normal-vs-N1 |
1.91851999999937E-05 |
| Normal-vs-N2 |
8.732100E-02 |
| N0-vs-N1 |
1.000000E+00 |
| N0-vs-N2 |
4.335200E-01 |
| N1-vs-N2 |
4.225200E-01 |
|
|
